{"id":"CHEMBL1029","canonicalSmiles":"CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO","inchiKey":"UQRORFVVSGFNRO-UTINFBMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIGLUSTAT","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zavesca"],"synonyms":["Miglustat","OGT 918","OGT-918"],"crossReferences":{"DailyMed":["miglustat"],"PubChem":["144204381","170464950"],"Wikipedia":["Miglustat"],"drugbank":["DB00419"],"chEBI":["50381"]},"childChemblIds":["CHEMBL1329690"],"count":7,"linkedTargets":{"rows":["ENSG00000148154"],"count":1},"linkedDiseases":{"rows":["Orphanet_77259","Orphanet_646","Orphanet_796","EFO_0000764","Orphanet_309152","Orphanet_355","Orphanet_586"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 7 investigational indications."}
{"id":"CHEMBL1045","canonicalSmiles":"O=C(O)c1ccccc1C(=O)O","inchiKey":"XNGIFLGASWRNHJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHTHALIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phthalic acid"],"crossReferences":{"PubChem":["144208113","17389679","56436658"],"drugbank":["DB02746"],"chEBI":["29069"]},"childChemblIds":["CHEMBL3187152"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108483","canonicalSmiles":"N#Cc1ccc(N(Cc2ccc(OS(N)(=O)=O)c(Br)c2)n2cnnc2)cc1","inchiKey":"GHDKYBCUDPSXGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL108483","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04600"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1089222","canonicalSmiles":"NCCCC[C@H](N)C(=O)O.O=C(O)COc1nn(Cc2ccccc2)c2ccccc12","inchiKey":"OCOCFNMFLNFNIA-ZSCHJXSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENDAZAC LYSINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1089221","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bendazac Lysine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1098","canonicalSmiles":"CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C","inchiKey":"LEBVLXFERQHONN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPIVACAINE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anekain","Exparel","Marcaine","Sensorcaine"],"synonyms":["Bupivacaine","LIQ-865","LIQ865","Marcaine","Ropivacaine hydrochloride impurity, bupivacaine-","SKY-0402","SKY0402","Sensorcaine"],"crossReferences":{"DailyMed":["bupivacaine","bupivacaine%20hydrochloride"],"PubChem":["160644527"],"Wikipedia":["Bupivacaine"],"drugbank":["DB00297"],"chEBI":["77431"]},"childChemblIds":["CHEMBL1200396"],"count":58,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000007314"],"count":1},"linkedDiseases":{"rows":["HP_0003470","EFO_0005232","EFO_0003869","EFO_0003777","EFO_1001139","EFO_0007486","HP_0030838","HP_0012227","EFO_0000275","MONDO_0002959","MONDO_0004567","HP_0000175","HP_0031217","EFO_1001909","EFO_1000994","EFO_0003964","MONDO_0001416","EFO_0003931","HP_0100790","EFO_0002506","MONDO_0002471","EFO_1000786","MONDO_0008903","EFO_1001898","EFO_0004616","HP_0003419","EFO_0009552","EFO_0009620","EFO_1002012","EFO_0003877","EFO_1001250","EFO_0005762","EFO_0002618","HP_0000016","EFO_0001074","HP_0001623","HP_0012532","EFO_0009512","EFO_0003821","EFO_0010072","HP_0009926","EFO_1001968","HP_0030016","MONDO_0008315","EFO_0000546","MP_0001914","HP_0001537","HP_0003040","EFO_0000731","EFO_0003957","EFO_0004888","EFO_0004209","EFO_0000342","EFO_1001792","EFO_0005251","EFO_0004248","MONDO_0021117","MONDO_0007254","EFO_0000284","MONDO_0002087","MONDO_0004565","EFO_0002950","MONDO_0022394","EFO_0009514","EFO_1001866","EFO_0007202","HP_0030834","EFO_0004143","HP_0100749","HP_0001822","EFO_0009625","EFO_0007490","EFO_0000616","EFO_0004210","HP_0000486","HP_0003418","EFO_1001267","EFO_0001073","EFO_0003843","HP_0002315","EFO_0003060","EFO_0000311","EFO_0004229","EFO_0007149","Orphanet_98578","EFO_1001412","EFO_0000537","EFO_0009614","EFO_0000764","HP_0000020","EFO_0001421","EFO_0004273","EFO_0003766","EFO_0005611","EFO_0009314","EFO_0003833","EFO_0000691","HP_0000023","EFO_0003944","EFO_0009615","EFO_0004710"],"count":101},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and is indicated for pain and has 57 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1104","canonicalSmiles":"CC[N+](C)(C)c1cccc(O)c1","inchiKey":"VWLHWLSRQJQWRG-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"EDROPHONIUM","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ENLON-PLUS","Edrophonium","Enlon","Reversol","Tensilon"],"crossReferences":{"PubChem":["11111143","11111144","50100235","50104222","90341680"],"drugbank":["DB01010"],"chEBI":["251408"]},"childChemblIds":["CHEMBL60745","CHEMBL1128"],"count":2,"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["Orphanet_230","EFO_1000645","HP_0002571","EFO_0005252"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1951 and has 2 investigational indications."}
{"id":"CHEMBL1144","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21","inchiKey":"TUZYXOIXSAXUGO-PZAWKZKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAVASTATIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["C10AA03","Pravachol","Pravastatin"],"crossReferences":{"DailyMed":["pravastatin%20sodium"],"Wikipedia":["Pravastatin"],"drugbank":["DB00175"],"chEBI":["63618"]},"childChemblIds":["CHEMBL690"],"count":31,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","EFO_0003774","EFO_1000727","EFO_0004246","EFO_0000565","EFO_0003913","EFO_1001375","EFO_0002690","EFO_0003144","EFO_0006890","EFO_0000182","EFO_0003884","MONDO_0020732","MONDO_0008903","EFO_0000400","EFO_0000692","EFO_0000685","HP_0002140","HP_0003124","HP_0001919","EFO_0001645","EFO_0000180","EFO_0003929","EFO_0000313","EFO_0000319","Orphanet_740","Orphanet_3389","EFO_1001496","Orphanet_309005","EFO_0000537","EFO_0003106","MONDO_0002691","Orphanet_412","EFO_1000049","EFO_1001121","EFO_0000764","Orphanet_79211","EFO_0001359","EFO_0000574","EFO_0008583","EFO_0000612","EFO_0001360","EFO_0003918","EFO_0005411","EFO_0000668","EFO_0005672"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for cardiovascular disease and has 30 investigational indications."}
{"id":"CHEMBL1160695","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccc(O)cc1","inchiKey":"OXFGTKPPFSCSMA-XVKPBYJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160695","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11610"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200328","canonicalSmiles":"CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl","inchiKey":"BFFSMCNJSOPUAY-LMOVPXPDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DULOXETINE HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1175","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ariclaim","Cymbalta","Drizalma sprinkle","Duciltia","Duloxetine hydrochloride","Yentreve"],"synonyms":["Duloxetine hydrochloride","LY-248686","LY-248686 HCL","LY248686 HCL"],"crossReferences":{"DailyMed":["duloxetine%20hydrochloride"],"PubChem":["144205741","170465319","49681598"],"chEBI":["31526"]},"count":12,"approvedIndications":["EFO_0005687","MONDO_0002009","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0003885","EFO_1000783","EFO_0005687","MONDO_0002050","EFO_0002506","MONDO_0002009","HP_0000020","EFO_0003761","EFO_0001358","EFO_0005230","EFO_0003843","EFO_1001951"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200330","canonicalSmiles":"CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C.Cl","inchiKey":"RNAICSBVACLLGM-GNAZCLTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PILOCARPINE HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL550","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isopto carpine","Ocusert","Piloc hcl","Pilocarpine hydrochloride","Pilogel","Pilopine","Pilopine hs","Salagen","Sno pilo"],"synonyms":["Pilocarpine hydrochloride","Salagen"],"crossReferences":{"DailyMed":["pilocarpine%20hydrochloride"],"PubChem":["26719685","50106827","539062","855931"]},"count":1,"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0006859","EFO_1001914"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and has 1 investigational indication."}
{"id":"CHEMBL1200393","canonicalSmiles":"Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1.Cl","inchiKey":"IEPMBYOIQGCVHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GREPAFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL583","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," United States"," Germany"],"classes":["Cardiotoxicity"],"year":1999},"tradeNames":["Raxar"],"synonyms":["Grepafloxacin hydrochloride","OPC-17116"],"crossReferences":{"PubChem":["144206077","170466148"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in United States,  United Kingdom,  United States and  Germany initially in 1999 due to Cardiotoxicity."}
{"id":"CHEMBL1200544","canonicalSmiles":"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1.O","inchiKey":"AVGYWQBCYZHHPN-CYJZLJNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALEXIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1727","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cephalexin","Ceporex","Keflet","Keflex","Kiflone","Panixine disperdose","Tenkorex"],"synonyms":["66873","Cefalexin","Cefalexin hydrate","Cefalexin monohydrate","Cephalexin","Cephalexin monohydrate","LY-66873"],"crossReferences":{"DailyMed":["cephalexin"],"chEBI":["3535"]},"count":12,"approvedIndications":["EFO_0000771","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for bacterial disease and infection and has 10 investigational indications."}
{"id":"CHEMBL1200714","canonicalSmiles":"CN1C(=O)CCS(=O)(=O)C1c1ccc(Cl)cc1","inchiKey":"WEQAYVWKMWHEJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORMEZANONE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," European Union"," Germany"," France"," Japan"," Pakistan"," Portugal"," United Arab Emirates"," Zimbabwe"," Saudi Arabia"],"classes":["Dermatological toxicity"," Hepatotoxicity"],"year":1996},"tradeNames":["Lyseen new","Trancopal"],"synonyms":["Chlormethazanone","Chlormezanone"],"crossReferences":{"PubChem":["104171118","144203644","144206702","144212514","170465161","26747112","26751725","50104419","85230949","90340648"],"TG-GATEs":["52"],"Wikipedia":["Chlormezanone"],"drugbank":["DB01178"],"chEBI":["3619"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960. It was withdrawn in United States,  European Union,  Germany,  France,  Japan,  Pakistan,  Portugal,  United Arab Emirates,  Zimbabwe and  Saudi Arabia initially in 1996 due to Dermatological toxicity and  Hepatotoxicity."}
{"id":"CHEMBL1200771","canonicalSmiles":"CC[N+](CC)(CC)CCC(O)(c1ccccc1)C1CCCCC1.[Cl-]","inchiKey":"XJGONMZLEDGBRM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDIHEXETHYL CHLORIDE","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201354","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pathilon"],"synonyms":["Tridihexethyl chloride"],"crossReferences":{"PubChem":["144204284","56463141"],"chEBI":["9703"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954."}
{"id":"CHEMBL1200859","canonicalSmiles":"CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2cc(S(=O)(=O)[O-])ccc2S(=O)(=O)[O-])cc1.[Na+]","inchiKey":"NLUFDZBOHMOBOE-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOSULFAN BLUE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201275","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isosulfan blue","Lymphazurin"],"synonyms":["Isosulfan blue","P-1888","P-4125","Sulphan blue","Sulphan blue 2,5-disulfophenyl isomer"],"crossReferences":{"DailyMed":["isosulfan%20blue"],"DrugCentral":["4503"],"PubChem":["170464639"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1981 and has 1 investigational indication."}
{"id":"CHEMBL1200876","canonicalSmiles":"CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl","inchiKey":"MBGXILHMHYLZJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXAPRAM HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1754","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Dopram","Doxapram HCl","Stimulexin"],"synonyms":[],"crossReferences":{"PubChem":["144206016","170465313"],"chEBI":["59837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200912","canonicalSmiles":"CC(C)(N)Cc1ccccc1.Cl","inchiKey":"NCAIGTHBQTXTLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENTERMINE HYDROCHLORIDE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1574","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adipex-p","Fastin","Lomaira","Obestin-30","Oby-trim","Ona-mast","Phentermine hydrochloride","Suprenza","Tora","Wilpo"],"synonyms":["NSC-44090","Phentermine hydrochloride","Phentermine hydrochloride civ"],"crossReferences":{"DailyMed":["phentermine%20hydrochloride"],"chEBI":["50506"]},"count":1,"approvedIndications":["EFO_0001073"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","EFO_0001073"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973 and is indicated for obesity."}
{"id":"CHEMBL1201071","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.O=P(O)(O)O","inchiKey":"WXDJNRXQVCECPF-FMZCEJRJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRACYCLINE PHOSPHATE COMPLEX","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1440","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":["Tetrex"],"synonyms":["Tetracycline metaphosphate","Tetracycline phosphate complex"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957. It was withdrawn in United States."}
{"id":"CHEMBL1201081","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)[O-])[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12.[Na+]","inchiKey":"FQISKWAFAHGMGT-SGJOWKDISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE SODIUM SUCCINATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201265","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["A-methapred","Methylprednisolone","Methylprednisolone sodium succinate","Min-i-mix","Solu-medrol","Solu-medrone","Urbasone"],"synonyms":["Methylprednisolone 21-succinate sodium salt","Methylprednisolone sodium succinate","NSC-48989"],"crossReferences":{"DailyMed":["methylprednisolone%20sodium%20succinate"],"PubChem":["144207076"]},"count":27,"approvedIndications":["EFO_0003885","EFO_0000685","EFO_0000270","EFO_0003894"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","MONDO_0002462","EFO_0009267","EFO_0005952","EFO_0000540","EFO_0000565","EFO_0000474","EFO_0002690","EFO_0003884","EFO_0004616","Orphanet_700","EFO_0005140","EFO_0008522","EFO_1001272","EFO_0000198","EFO_0000694","MONDO_0013730","EFO_0000685","EFO_0000220","Orphanet_701","EFO_0007537","EFO_1001466","EFO_0000222","EFO_0004194","EFO_0003894","EFO_0003843","EFO_0004599","EFO_0003106","EFO_0003885","HP_0100806","MP_0001845","EFO_0003840","MONDO_0100096","EFO_0000095","EFO_0000270","EFO_0007359","EFO_0000341","EFO_0001378","EFO_0001063"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 4 approved and 23 investigational indications."}
{"id":"CHEMBL1201182","canonicalSmiles":"CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C","inchiKey":"CBPNZQVSJQDFBE-FUXHJELOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMSIROLIMUS","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Torisel"],"synonyms":["CCI-779","Temsirolimus"],"crossReferences":{"DailyMed":["temsirolimus"],"PubChem":["144206068"],"Wikipedia":["Temsirolimus"],"drugbank":["DB06287"],"chEBI":["79699"]},"count":74,"approvedIndications":["EFO_0000616","EFO_0000681","EFO_0000349","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000637","EFO_0000365","EFO_0000756","EFO_0000681","EFO_1000231","MONDO_0004222","EFO_0005952","EFO_0000228","EFO_1001187","EFO_0002917","EFO_0000565","EFO_1001952","EFO_0000339","MONDO_0002974","MONDO_0003268","EFO_0000389","EFO_1001331","EFO_0000182","EFO_1000251","MONDO_0008903","EFO_1000440","EFO_0000198","EFO_0000466","EFO_1000292","MONDO_0002108","EFO_0000248","MONDO_0008170","EFO_0000349","EFO_1001512","EFO_1001968","EFO_0000502","EFO_1000441","MONDO_0008315","EFO_0009708","EFO_1000026","MONDO_0002691","MONDO_0000544","EFO_1000238","EFO_0000574","MONDO_0002863","EFO_1000613","EFO_0001378","EFO_1000412","MONDO_0015686","MONDO_0004192","EFO_0007416","EFO_1001465","MONDO_0007254","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0020654","MONDO_0001187","MONDO_0016691","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0000673","EFO_0002499","EFO_0000183","MONDO_0024677","EFO_0000707","EFO_1000158","EFO_0002914","EFO_1000037","EFO_0000616","EFO_0000685","EFO_0000437","EFO_0000403","EFO_0000232","EFO_0000222","EFO_0003929","EFO_0000313","EFO_0002501","EFO_0000556","EFO_0000621","EFO_0003060","EFO_0000311","MONDO_0016693","EFO_0006861","MONDO_0011962","EFO_0000702","MONDO_0017386","MONDO_0002367","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_0000181","EFO_0004265","EFO_0000691"],"count":92},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 4 approved and 70 investigational indications."}
{"id":"CHEMBL1201466","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTROGENS, CONJUGATED SYNTHETIC A","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cenestin","Synthetic conjugated estrogens a"],"synonyms":["Estrogens, conjugated synthetic a"],"crossReferences":{"DailyMed":["estrogens,%20conjugated%20synthetic%20a"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201545","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE BEEF","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nph insulin"],"synonyms":["Insulin susp isophane beef"],"count":3,"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0004593","EFO_0001359","HP_0003074","EFO_0001360","EFO_0000400"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 investigational indications."}
{"id":"CHEMBL1201585","drugType":"Antibody","blackBoxWarning":true,"name":"TRASTUZUMAB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Herceptin","Kadcyla"],"synonyms":["4D5V8","ABP 980","ABP-980","DMB-3111 (TRASTUZUMAB BIOSIMILAR)","EG-12014","EG12014","Pf-05280014","R-597","SYD-977","SYD977","Trastuzumab","Trastuzumab beta"],"crossReferences":{"DailyMed":["trastuzumab","trastuzumab-anns","trastuzumab-dkst","trastuzumab-dttb","trastuzumab-pkrb"],"DrugCentral":["4979"],"Wikipedia":["Trastuzumab"]},"count":61,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0000637","EFO_0005952","EFO_0000228","EFO_1001187","EFO_1000984","EFO_1001951","EFO_0000565","MONDO_0002974","MONDO_0008903","MONDO_0005411","MONDO_0001528","EFO_0000501","EFO_0000641","EFO_1000028","EFO_0002618","MONDO_0019465","MONDO_0021321","MONDO_0008170","MONDO_0004669","EFO_1001512","MONDO_0044915","MONDO_0008315","EFO_0005221","MONDO_0001879","EFO_0009708","EFO_1000307","EFO_0000549","Orphanet_398934","EFO_0000432","EFO_1001051","EFO_0006544","EFO_1000796","EFO_0009637","EFO_0000292","MONDO_0044964","MONDO_0004192","MONDO_0007254","MONDO_0003196","MONDO_0001370","MONDO_0002087","EFO_0000305","MONDO_0003510","MONDO_0020654","MONDO_0021165","MONDO_0001187","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_1000044","EFO_0003968","EFO_0006352","MONDO_0021311","EFO_0000183","EFO_0005588","EFO_0000616","EFO_0003897","MONDO_0001402","EFO_0006859","EFO_0005774","EFO_0006318","EFO_0002916","EFO_0000503","MONDO_0007576","EFO_0000313","EFO_0000222","EFO_0003060","EFO_0000311","EFO_0003863","EFO_0000304","EFO_0006861","MONDO_0011962","MONDO_0003219","MONDO_0024880","EFO_0000691","MONDO_0044926"],"count":77},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 5 approved and 56 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201605","drugType":"Antibody","blackBoxWarning":false,"name":"DACLIZUMAB","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zenapax","Zinbryta"],"synonyms":["Daclizumab","Daclizumab beta","RO 24-7375","RO-24-7375"],"crossReferences":{"DrugCentral":["4953"],"Wikipedia":["Daclizumab"]},"count":26,"approvedIndications":["EFO_0003929","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003086","EFO_0004683","MONDO_0019471","EFO_0000756","HP_0001915","MONDO_0019541","EFO_0000540","EFO_1002048","EFO_0000565","EFO_0003884","EFO_0000676","EFO_0000183","EFO_0000400","EFO_0000198","MONDO_0013730","EFO_0000616","EFO_0003929","EFO_0004599","HP_0001873","MONDO_0001705","Orphanet_567","EFO_0003885","EFO_1001231","EFO_0005297","EFO_0000270","EFO_0001359","EFO_0000764","EFO_0000574","EFO_0001378","HP_0012410"],"count":31},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for immune system disease and relapsing-remitting multiple sclerosis and has 24 investigational indications."}
{"id":"CHEMBL1201646","drugType":"Unknown","blackBoxWarning":false,"name":"INULIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inulin and sodium chloride"],"synonyms":["Inulin"],"crossReferences":{"DrugCentral":["1447"],"Wikipedia":["Inulin"]},"count":4,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1201649","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTROGENS, CONJUGATED","yearOfFirstApproval":1942,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cenestin","Oestrogen","Premarin","Premarin Cream"],"synonyms":["Conjugated estrogens","Estrogens conjugated","Estrogens, conjugated","G03CA57","Oestrogens conjugated"],"crossReferences":{"DailyMed":["estrogens,%20conjugated"],"DrugCentral":["4855"]},"count":30,"approvedIndications":["EFO_0003854"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_1001864","EFO_0000249","MONDO_0007254","HP_0031217","EFO_0003882","EFO_1001271","HP_0000938","EFO_0003103","HP_0002907","MONDO_0041161","EFO_0004714","EFO_1001375","EFO_0002690","EFO_0004266","EFO_0000712","EFO_0000400","EFO_0004215","EFO_0004288","EFO_0000545","HP_0003124","EFO_0002687","EFO_0002508","EFO_0001645","EFO_0001073","MONDO_0008315","EFO_0001663","EFO_0000537","EFO_0001072","EFO_1000985","MONDO_0000831","EFO_0003854","MONDO_0011962","EFO_1000781","EFO_0000612","Orphanet_881","MONDO_0043510","HP_0031273","EFO_0003922"],"count":39},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1942 and is indicated for postmenopausal osteoporosis and has 29 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1207358","canonicalSmiles":"O=C(O)c1cc(=O)[nH]c(=O)n1[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"KYOBSHFOBAOFBF-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OROTIDINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Orotidine Monophosphate"],"crossReferences":{"drugbank":["DB02957"],"chEBI":["15842"]},"childChemblIds":["CHEMBL1627081"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213250","canonicalSmiles":"Cn1c(N)c(NC(=O)NCCN)c[n+]1CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\\OC(C)(C)C(=O)[O-])c3nsc(N)n3)[C@H]2SC1.O=S(=O)(O)O","inchiKey":"UJDQGRLTPBVSFN-TVNHLQOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOLOZANE SULFATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103872","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CXA-101 (FOR SULFATE)","Ceftolozane sulfate","FR264205"],"crossReferences":{"DailyMed":["ceftolozane%20sulfate"]},"count":2,"approvedIndications":["EFO_0003103","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for infection and urinary tract infection."}
{"id":"CHEMBL1231661","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)NCB(O)O)c1csc(N)n1)C(=O)O","inchiKey":"ZECCQELUYUPTSB-UUASQNMZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTAZIDIME BATSI","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ceftazidime Batsi"],"crossReferences":{"drugbank":["DB04035"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231891","canonicalSmiles":"Cc1c2[nH]c(c1CCC(=O)O)Cc1[nH]c(c(CCC(=O)O)c1C)Cc1[nH]c(c(CCC(=O)O)c1C)Cc1[nH]c(c(C)c1CCC(=O)O)C2","inchiKey":"NIUVHXTXUXOFEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COPROPORPHYRINOGEN-III","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coproporphyrinogen-Iii"],"crossReferences":{"drugbank":["DB04461"],"chEBI":["15439"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234930","canonicalSmiles":"CCCCCCCC(=O)O[C@H](CC(=O)O)C[N+](C)(C)C","inchiKey":"CXTATJFJDMJMIY-CYBMUJFWSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTANOYLCARNITINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113593"],"drugbank":["DB03832"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235716","canonicalSmiles":"CCC(N)=O","inchiKey":"QLNJFJADRCOGBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPIONAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04161"],"chEBI":["45422"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236126","canonicalSmiles":"CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO","inchiKey":"CEAYRKIZESVQSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236126","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103905081","137275845"],"drugbank":["DB08590"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237021","canonicalSmiles":"O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1","inchiKey":"PQXKDMSYBGKCJA-CVTJIBDQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LURASIDONE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Latuda"],"synonyms":["Lurasidone"],"crossReferences":{"DailyMed":["lurasidone%20hydrochloride"],"Wikipedia":["Lurasidone"],"drugbank":["DB08815"],"chEBI":["70735"]},"childChemblIds":["CHEMBL1615372"],"count":7,"approvedIndications":["EFO_0005407","EFO_0005411"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0000289","MONDO_0002050","MONDO_0002009","EFO_0000677","EFO_0003758","EFO_0009963","EFO_0005407","EFO_0000692","EFO_0005411"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for psychosis and schizoaffective disorder and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1241590","canonicalSmiles":"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)cc1","inchiKey":"AYIRNRDRBQJXIF-NXEZZACHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORFENICOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Florfenicol","SCH 25298"],"crossReferences":{"PubChem":["144204234","170465648","56463547"],"Wikipedia":["Florfenicol"],"drugbank":["DB11413"],"chEBI":["87185"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256140","canonicalSmiles":"C[C@@H]1O[C@@H]1P(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"QZIQJIKUVJMTDG-JSTPYPERSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PHOSPHOMYCIN DISODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1757","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phosphomycin Disodium"],"crossReferences":{"PubChem":["57261353"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256391","canonicalSmiles":"Cc1ccc(=O)n(-c2ccccc2)c1","inchiKey":"ISWRGOKTTBVCFA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRFENIDONE","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Esbriet"],"synonyms":["AMR-69","Pirfenidone"],"crossReferences":{"DailyMed":["pirfenidone"],"PubChem":["11113908","144203776","170465606","46500438","50104718","85231182","90341749"],"Wikipedia":["Pirfenidone"],"drugbank":["DB04951"],"chEBI":["32016"]},"count":22,"approvedIndications":["EFO_0000768","EFO_0000540"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for immune system disease and idiopathic pulmonary fibrosis and has 20 investigational indications."}
{"id":"CHEMBL1256472","canonicalSmiles":"Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1","inchiKey":"KCURWTAZOZXKSJ-JBMRGDGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTARABINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL803","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytarabine hydrochloride","Cytosine arabinoside hydrochloride","NSC-63878","U-19920A"],"crossReferences":{"PubChem":["144210806","50106080","56424029","8139915"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1256819","canonicalSmiles":"Cl.c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1","inchiKey":"SWKDMSRRIBZZAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTAZOLINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1305","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Antaz hcl","R.b.c."],"synonyms":["Antazoline hydrochloride"],"crossReferences":{"PubChem":["144204075","170464765","56422365","56463312","855763"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1371770","canonicalSmiles":"c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1","inchiKey":"OQDPVLVUJFGPGQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRIBEDIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trivastal","Trivastal lp"],"synonyms":["ET-495","EU-4200","Piribedil"],"crossReferences":{"PubChem":["104171222","11111687","11111688","11113867","144203796","170466242","90341513"],"Wikipedia":["Piribedil"],"drugbank":["DB12478"]},"childChemblIds":["CHEMBL4594075","CHEMBL1865834","CHEMBL1256997","CHEMBL1468572"],"count":1,"approvedIndications":["EFO_0002508"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for parkinson's disease."}
{"id":"CHEMBL1401","canonicalSmiles":"CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1","inchiKey":"YQNQNVDNTFHQSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NITAZOXANIDE","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alinia"],"synonyms":["NSC-697855","Nitazoxanide","PH 5776","PH-5776"],"crossReferences":{"DailyMed":["nitazoxanide"],"PubChem":["124889979","144204569","144208424","170465090","17388853","26719875","49681590","525698"],"Wikipedia":["Nitazoxanide"],"drugbank":["DB00507"]},"count":19,"approvedIndications":["HP_0002014"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for diarrhea and has 18 investigational indications."}
{"id":"CHEMBL1435413","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@@H]2[C@@H](O)c1ccnc2ccc(OC)cc12.Cl.O","inchiKey":"SGVZDMWHXVXUBY-KAIFKDDSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1435413","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1294","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56320896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1437847","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2cnc3ccccc3n2)cc1","inchiKey":"NHZLNPMOSADWGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFAQUINOXALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfaquinoxaline"],"crossReferences":{"PubChem":["144203578","144211211","170465653","26665745","4252936","96536"],"drugbank":["DB11464"]},"childChemblIds":["CHEMBL1527324"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1443447","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.Cl.O","inchiKey":"UJEMGEUVWHFXGB-XYQGXRRISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1443447","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1167","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49647611"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1467","canonicalSmiles":"O=c1ncnc2[nH][nH]cc1-2","inchiKey":"OFCNXPDARWKPPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOPURINOL","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allopurinol","Aloral","Aluline 100","Aluline 300","Caplenal","Cosuric","Hamarin 100","Hamarin 300","Ledopur","Lopurin","Uricto","Xanthomax-100","Xanthomax-300","Zyloprim","Zyloric","Zyloric-300"],"synonyms":["Allopurinol","BW 56-158","BW-56-158","NSC-101655","NSC-1390"],"crossReferences":{"DailyMed":["allopurinol","allopurinol%20sodium"],"PubChem":["11110781","144203633","144208120","170464935","17389550","174007214","26747845","50105533","56424020","8139898","90341357"],"TG-GATEs":["28"],"Wikipedia":["Allopurinol"],"drugbank":["DB00437"],"chEBI":["40279"]},"childChemblIds":["CHEMBL1200477"],"count":37,"approvedIndications":["EFO_0000565","EFO_0004274","EFO_0000574","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003777","EFO_0004274","EFO_0000401","EFO_0000373","EFO_0005952","MONDO_0002087","MONDO_0003541","EFO_1001793","EFO_0003913","EFO_0000565","EFO_1000653","Orphanet_46","MONDO_0002158","EFO_0000289","EFO_0004251","EFO_0002506","EFO_0009582","EFO_0003144","EFO_0004253","EFO_0003884","EFO_0000712","EFO_1002032","Orphanet_976","EFO_1001479","EFO_1001893","EFO_0000400","EFO_0000692","EFO_0000198","EFO_0009104","EFO_0005044","EFO_0000220","MONDO_0008170","EFO_0005207","Orphanet_3389","EFO_0000222","EFO_0000319","EFO_1001946","EFO_0001073","EFO_0000537","EFO_0000311","EFO_0000195","EFO_0000095","EFO_0000574","EFO_1001947","EFO_0001378","EFO_0001360","EFO_0005411","EFO_0003767","EFO_0005672","EFO_0004265"],"count":51},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and has 4 approved and 33 investigational indications."}
{"id":"CHEMBL1491306","canonicalSmiles":"Oc1cc(Cc2ccccc2)nc(S)n1","inchiKey":"PNXBXCRWXNESOV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZYLTHIOURACIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Basdene"],"synonyms":["Benzylthiouracil"],"crossReferences":{"PubChem":["22402305"],"drugbank":["DB13804"]},"count":1,"approvedIndications":["HP_0000820"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for abnormality of the thyroid gland."}
{"id":"CHEMBL1497","canonicalSmiles":"CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"SNHRLVCMMWUAJD-SUYDQAKGSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BETAMETHASONE VALERATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Audavate","Audavate rd","Beta-val","Betacap","Betaderm","Betameth val in coal tar","Betamethasone valerate","Betatrex","Betesil","Betnovate rd","Betnovate-c","Betnovate-n","Bettamousse","Bextasol","Dermabet","Fucibet","Luxiq","Valisone","Valnac","Xemacort"],"synonyms":["Betamethasone 17-valerate","Betamethasone valerate"],"crossReferences":{"DailyMed":["betamethasone%20valerate"],"PubChem":["144212605"],"Wikipedia":["Betamethasone_17-valerate"],"chEBI":["31277"]},"count":6,"approvedIndications":["HP_0006536","EFO_0009552","HP_0001742","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0006536","HP_0000964","EFO_1001818","EFO_0000701","EFO_0000676","EFO_0009552","EFO_0000274","HP_0001742","HP_0004798","EFO_0005752"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and has 4 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1512080","canonicalSmiles":"CN1C(=O)/C(=N\\NC(N)=S)c2ccccc21","inchiKey":"DLGSOJOOYHWROO-WQLSENKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHISAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BW 33-T-57","Methisazone","Metisazone"],"crossReferences":{"PubChem":["26757941"],"Wikipedia":["Metisazone"],"drugbank":["DB13641"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL151803","canonicalSmiles":"S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1","inchiKey":"QFVAWNPSRQWSDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULBENTINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D 47","Dibenzathione","Dibenzthion","Sulbentine"],"crossReferences":{"PubChem":["144205485","29216291","50085920"],"drugbank":["DB13671"],"chEBI":["31477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1556","canonicalSmiles":"O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"UGQMRVRMYYASKQ-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INO-1001","Inosine","NSC-20262"],"crossReferences":{"PubChem":["144205075","170465655","8139984"],"Wikipedia":["Inosine"],"drugbank":["DB04335"],"chEBI":["17596"]},"childChemblIds":["CHEMBL1213651"],"count":9,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1569487","canonicalSmiles":"CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O","inchiKey":"WLHQHAUOOXYABV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LORNOXICAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xefo"],"synonyms":["CTX","Lornoxicam","RO 13-9297","RO-13-9297","RO-139297"],"crossReferences":{"PubChem":["49666507"],"drugbank":["DB06725"],"chEBI":["31783"]},"count":4,"approvedIndications":["EFO_0005755"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 3 investigational indications."}
{"id":"CHEMBL1615369","canonicalSmiles":"CCCCCCOC(=O)/N=C(\\N)c1ccc(NCc2nc3cc(C(=O)N(CCC(=O)OCC)c4ccccn4)ccc3n2C)cc1.CS(=O)(=O)O","inchiKey":"XETBXHPXHHOLOE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DABIGATRAN ETEXILATE MESYLATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL539697","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pradaxa"],"synonyms":["BIBR 1048 MS","BIBR-1048-MS","Dabigatran etexilate mesilate","Dabigatran etexilate mesylate"],"crossReferences":{"DailyMed":["dabigatran%20etexilate%20mesylate"],"chEBI":["70743"]},"count":4,"approvedIndications":["EFO_0000275","EFO_0000712","EFO_0003907"],"linkedTargets":{"rows":["ENSG00000180210"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000712","EFO_1000652","EFO_0003907"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1623","canonicalSmiles":"Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1","inchiKey":"OCJYIGYOJCODJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLIZINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Meclizine","Meclozine","NSC-169189"],"crossReferences":{"DailyMed":["meclizine%20hydrochloride"],"Wikipedia":["Meclozine"],"drugbank":["DB00737"],"chEBI":["6709"]},"childChemblIds":["CHEMBL1200590","CHEMBL1324020","CHEMBL3989555","CHEMBL1085765"],"count":4,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","EFO_0006928","HP_0002321","EFO_0000182","HP_0002013","EFO_0003785"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for allergy and has 3 investigational indications."}
{"id":"CHEMBL1624126","canonicalSmiles":"CN(CCO)CC(O)Cn1cnc2c1c(=O)n(C)c(=O)n2C","inchiKey":"DSFGXPJYDCSWTA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANTHINOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09092"]},"childChemblIds":["CHEMBL1560089"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1650818","canonicalSmiles":"CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](/N=C/N3CCCCCC3)[C@H]2SC1(C)C","inchiKey":"NPGNOVNWUSPMDP-UTEPHESZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMDINOCILLIN PIVOXIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Coactabs","Selexid"],"synonyms":["Amdinocillin pivoxil","Pivmecillinam","Pivmecillinam hydrochloride","RO 10-9071","RO-10-9071"],"childChemblIds":["CHEMBL4303519"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL1652465","canonicalSmiles":"CC(C)COC(=O)[C@H](Cc1ccccc1)NP(=O)(COCCn1cnc2c(NC3CC3)nc(N)nc21)N[C@@H](Cc1ccccc1)C(=O)OCC(C)C","inchiKey":"YTMOQFAFGKLYIW-CONSDPRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS-9191","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-9191","Gs-9191"],"crossReferences":{"drugbank":["DB15084"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1670","canonicalSmiles":"Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1","inchiKey":"JWBOIMRXGHLCPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MITOTANE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lysodren","Opddd"],"synonyms":["CB 313","CB-313","Mitotane","NSC-38721","O,p'-ddd"],"crossReferences":{"DailyMed":["mitotane"],"PubChem":["104171128","144203654","144213121","170464927","17389949","174007193","26747348","26752984","50105583","56462780","85230966","90341596","94579"],"Wikipedia":["Mitotane"],"drugbank":["DB00648"]},"count":4,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000140459","ENSG00000160882"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000313","EFO_1000796","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for neoplasm and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1707604","canonicalSmiles":"COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC.Cl.O","inchiKey":"ICKXRKHJKXMFLR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1707604","maximumClinicalTrialPhase":0,"parentId":"CHEMBL6966","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26719761"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743082","drugType":"Antibody","blackBoxWarning":true,"name":"TRASTUZUMAB EMTANSINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ado-trastuzumab emtansine","PRO-132365","RG-3502","TRASTUZUMAB-MCC-DM1 T-DM1","Trastuzumab emtansine"],"crossReferences":{"DailyMed":["ado-trastuzumab%20emtansine"],"DrugCentral":["4990"]},"count":8,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000141736","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_1001480","EFO_0003869","EFO_0000304","MONDO_0007254","MONDO_0004669","EFO_0000305","EFO_0003060","EFO_0000311","EFO_0009708"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 5 approved and 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1770","canonicalSmiles":"Cl.c1ccc([C@H]2CN3CCSC3=N2)cc1","inchiKey":"LAZPBGZRMVRFKY-HNCPQSOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVAMISOLE HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1454","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ergamisol","Ketrax","Solaskil"],"synonyms":["Levamisole hydrochloride","NSC-177023","R 12,564","R 12654","R-12564"],"crossReferences":{"PubChem":["144204834","170465293","50106504","564189","56463293"],"chEBI":["6433"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 2 investigational indications."}
{"id":"CHEMBL1893554","canonicalSmiles":"C[C@]12Cc3nonc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O","inchiKey":"RGLLOUBXMOGLDQ-IVEVATEUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FURAZABOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Furazabol"],"crossReferences":{"PubChem":["144206325","50125887"],"drugbank":["DB01514"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190729","canonicalSmiles":"CC1=C(C(=O)Nc2ccc(Cl)c(C(=O)OC(C)C)c2)SCCO1","inchiKey":"FMQGUMRNTBJHEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190729","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["487570"],"drugbank":["DB08682"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908364","canonicalSmiles":"O=C1CC[C@@](c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1","inchiKey":"LQQIVYSCPWCSSD-HSZRJFAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXETIMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexetimide","R 16,470 [AS HYDROCHLORIDE]"],"crossReferences":{"drugbank":["DB08997"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL19449","canonicalSmiles":"CC(C)C(=O)c1c(C(C)C)nn2ccccc12","inchiKey":"ZJVFLBOZORBYFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUDILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AV-411","AV411","Ibudilast","MN-166"],"crossReferences":{"PubChem":["11114182","124880396","124880398","144207052","170466049","46500478","50104937","90341511"],"Wikipedia":["Ibudilast"],"drugbank":["DB05266"]},"count":11,"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000112541","ENSG00000113448","ENSG00000172572","ENSG00000138735","ENSG00000184588"],"count":7},"linkedDiseases":{"rows":["EFO_1000783","HP_0006536","EFO_0003840","MONDO_0002491","EFO_0003821","EFO_0000253","EFO_0007541","EFO_0004701","HP_0002196","EFO_0005611","EFO_0003843","EFO_0000519","EFO_0003829"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL2036958","canonicalSmiles":"CC1(CCCc2cc(=O)oc3[nH]c(=O)[nH]c(=O)c23)CC1","inchiKey":"ARJKMWXLIHZLQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCH-900271","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH 900271","Sch 900271","Sch-900271"],"crossReferences":{"drugbank":["DB12433"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2068884","canonicalSmiles":"O=C([O-])[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O.[Na+]","inchiKey":"MSXHSNHNTORCAW-GGLLEASOSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM GLUCONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E-576-","E576","FEMA NO. 4934","Gluconate sodium","Gluconic acid sodium salt","INS NO.576","INS-576","Sodium gluconate"],"crossReferences":{"DrugCentral":["4214"]},"count":2,"approvedIndications":["MP_0001914"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for hemorrhage and has 1 investigational indication."}
{"id":"CHEMBL2103867","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(N)=O)CSSC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C(C)C)NC2=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N1)C(=O)O","inchiKey":"NSPHQWLKCGGCQR-DLJDZFDSSA-N","drugType":"Protein","blackBoxWarning":true,"name":"PLECANATIDE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trulance"],"synonyms":["Plecanatide","SP-304","SP-304 (SYNERGY)"],"crossReferences":{"drugbank":["DB13170"]},"count":2,"approvedIndications":["HP_0002019"],"linkedTargets":{"rows":["ENSG00000070019"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","HP_0002019"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for constipation and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2104184","canonicalSmiles":"CO/N=C/[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C","inchiKey":"NRLIFEGHTNUYFL-QJDHNRDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRASOFENSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brasofensine"],"crossReferences":{"drugbank":["DB04857"]},"childChemblIds":["CHEMBL2106525"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104423","canonicalSmiles":"CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)[C@@H](C)C[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C","inchiKey":"VHKXXVVRRDYCIK-CWCPJSEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NARASIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Monteban"],"synonyms":["COMPOUND 79891","Narasin"],"crossReferences":{"PubChem":["144206098"],"drugbank":["DB11432"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104461","canonicalSmiles":"O=C1CN2CCOC2(c2ccccc2F)c2cc(Br)ccc2N1","inchiKey":"XDKCGKQHVBOOHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOXAZOLAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Haloxazolam"],"crossReferences":{"drugbank":["DB01476"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105613","canonicalSmiles":"CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]","inchiKey":"MSRILKIQRXUYCT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"DIVALPROEX SODIUM","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL109","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Depakote","Depakote cp","Depakote er","Divalproex sodium"],"synonyms":["ABBOTT 50711","ABBOTT-50711","Divalproex sodium","Semisodium valproate","Valproate semisodium","Valproic acid sodium salt (2:1)"],"crossReferences":{"DailyMed":["divalproex%20sodium"],"chEBI":["4667"]},"count":16,"approvedIndications":["EFO_1000877","EFO_0000289","EFO_0000474","EFO_0003761","HP_0002121"],"linkedTargets":{"rows":["ENSG00000112294"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000877","EFO_0004777","HP_0010865","HP_0000726","EFO_0003821","EFO_0003015","EFO_0000249","EFO_0003758","EFO_0009963","EFO_0001358","HP_0001250","EFO_0003829","HP_0000713","Orphanet_399","EFO_0004247","EFO_0000289","EFO_0000474","MONDO_0002050","EFO_0003761","EFO_0000717","EFO_0000692","HP_0002121","EFO_0005411"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 5 approved and 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105634","canonicalSmiles":"CO[C@]1(C(=O)N[C@@H]2CC[C@@]3(C)[C@@H](CC[C@@H]4[C@@H]3CC[C@@]3(C)[C@H]4CC[C@@H]3[C@H](C)CCCC(C)C)C2)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O1","inchiKey":"CHMRTBYTCBDIRG-JQZMMWJVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COLENEURAMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coleneuramide","MCC-257"],"crossReferences":{"drugbank":["DB14932"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105647","canonicalSmiles":"CC(=O)Nc1cccc(N2CCN(CCCCNS(=O)(=O)CC3CCCCC3)CC2)c1.Cl","inchiKey":"QBACIVGQRFVOBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALUZOTAN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL209821","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naluzotan hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105673","canonicalSmiles":"CCC[C@@H](C)C[C@H](N)CC(=O)O.Cl","inchiKey":"CFMZXQJDAJXNHS-WLYNEOFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMAGABALIN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103836","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imagabalin hydrochloride","PD 0332334-0002 (PF00195889-01)","PF00195889-01"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107027","canonicalSmiles":"O=C([O-])CCCCCCCNC(=O)c1ccccc1O.[Na+]","inchiKey":"UOENJXXSKABLJL-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SALCAPROZATE SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL16503","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-414","E414","SNAC","Salcaprozate sodium"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108359","drugType":"Antibody","blackBoxWarning":false,"name":"NIMOTUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Theraloc theracim"],"synonyms":["HR3","Nimotuzumab","OSAG 101","THERACIM-HR3","THERALOC"],"count":27,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_1000172","EFO_0002938","EFO_1000657","MONDO_0007254","EFO_0004252","EFO_0000228","EFO_1001951","MONDO_0001056","MONDO_0002974","MONDO_0008903","EFO_0000326","EFO_0000707","EFO_0002618","EFO_0003897","EFO_0000616","EFO_0006859","EFO_0005922","EFO_1001931","EFO_0002916","EFO_0005842","MONDO_0007576","EFO_0000313","EFO_0003060","MONDO_0002914","EFO_0000311","EFO_1000026","EFO_0001061","EFO_0000199","MONDO_0001325","EFO_0000519","EFO_0000181"],"count":31},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 27 investigational indications."}
{"id":"CHEMBL2108570","drugType":"Unknown","blackBoxWarning":true,"name":"ABOBOTULINUMTOXINA","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Abobotulinumtoxina","RTI-150","RTI150"],"crossReferences":{"DailyMed":["abobotulinumtoxina"]},"count":2,"linkedTargets":{"rows":["ENSG00000132639"],"count":1},"linkedDiseases":{"rows":["HP_0001257","EFO_1001896","MONDO_0000726","HP_0000486","EFO_0003821","HP_0000473","HP_0009762","EFO_0005422","EFO_1001145","Orphanet_1866","HP_0000951","HP_0000975","HP_0003419","EFO_1000781","Orphanet_304"],"count":15},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108615","drugType":"Cell","blackBoxWarning":false,"name":"LAPULEUCEL-T","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neuvenge"],"synonyms":["APC-8024","APC8024","Dn24-02","Lapuleucel-t"],"count":1,"description":"Cell drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109072","drugType":"Unknown","blackBoxWarning":false,"name":"FIBRINOGEN, HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Fibrogen"],"synonyms":["Factor i (fibrinogen)","Fibrinogen","Fibrinogen, human"],"count":9,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2109367","drugType":"Antibody","blackBoxWarning":false,"name":"LMB-2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LMB-2","Lmb-2"],"count":4,"linkedTargets":{"rows":["ENSG00000134460"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","MONDO_0019471","EFO_1000956","EFO_0000574"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109437","drugType":"Antibody","blackBoxWarning":false,"name":"KHK-2866","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KHK-2866","KHK2866","Khk-2866"],"count":3,"linkedTargets":{"rows":["ENSG00000113070"],"count":1},"linkedDiseases":{"rows":["EFO_0003893","EFO_1001100","EFO_1000251"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109443","drugType":"Antibody","blackBoxWarning":false,"name":"F105","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["F105"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109602","drugType":"Antibody","blackBoxWarning":false,"name":"IMC-3C5","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-3C5","Imc-3c5"],"count":1,"linkedTargets":{"rows":["ENSG00000037280"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109644","drugType":"Antibody","blackBoxWarning":false,"name":"TNT-1B","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cotara"],"synonyms":["TNT-1B","Tnt-1b"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110824","canonicalSmiles":"CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1","inchiKey":"CUWODFFVMXJOKD-UVLQAERKSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BUSERELIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Suprecur","Suprefact"],"synonyms":["Buserelin"],"childChemblIds":["CHEMBL2106198"],"count":3,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","Orphanet_64739","EFO_0000545","EFO_0000196","MONDO_0008315","EFO_0002950"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 2 investigational indications."}
{"id":"CHEMBL2111081","canonicalSmiles":"Cc1sc[n+](CC(=O)c2ccccc2)c1C","inchiKey":"LYLFQLCLUXOFOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALAGEBRIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alagebrium"],"crossReferences":{"drugbank":["DB12497"]},"childChemblIds":["CHEMBL2107309"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL211769","canonicalSmiles":"COC(=O)C[C@H]1CC(c2ccc(O)cc2)=NO1","inchiKey":"AIXMJTYHQHQJLU-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL211769","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07888"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2152047","canonicalSmiles":"O=C(O)[C@H](O)[C@@H](O)CO","inchiKey":"JPIJQSOTBSSVTP-STHAYSLISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-THREONIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-threonic acid"],"crossReferences":{"drugbank":["DB11192"],"chEBI":["15908"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2158685","canonicalSmiles":"O=C(NCc1ccncc1)C12CC3CC(C1)CC(c1ccc(Cl)cc1)(C3)C2","inchiKey":"CAOTVXGYTWCKQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABC-294640","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABC 294640","Abc-294640","Opaganib"],"crossReferences":{"PubChem":["174006706"],"drugbank":["DB12764"]},"count":6,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2170582","canonicalSmiles":"CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4c(c3)NC(=O)C(F)(F)O4)n2)c1","inchiKey":"MOXXQFNQDDSJHT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-343","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL3545340"],"count":1,"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0000270"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL219376","canonicalSmiles":"O=C(O)c1c(O)c(-c2ccccc2)nc2ccccc12","inchiKey":"XAPRFLSJBSXESP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYCINCHOPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxycincophene","Oxicinchophen","Oxycinchophen"],"crossReferences":{"PubChem":["170466564"],"drugbank":["DB13596"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL221572","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"NSKGQURZWSPSBC-VVPCINPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOSTAMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ribostamycin","Ribostamycin sulfate"],"crossReferences":{"drugbank":["DB03615"],"chEBI":["45257"]},"childChemblIds":["CHEMBL3138633"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2219536","canonicalSmiles":"COCCO[C@H]1[C@@H](O)[C@H](COP(=O)(O)S[C@H]2[C@H](COP(=O)(O)S[C@H]3[C@H](COP(=O)(O)S[C@H]4[C@H](COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5COP(=O)(O)S[C@H]5C[C@H](n6cnc7c(N)ncnc76)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(=O)[nH]c6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cc(C)c(N)nc6=O)O[C@@H]5COP(=O)(O)S[C@H]5[C@@H](OCCOC)[C@H](n6cnc7c(=O)[nH]c(N)nc76)O[C@@H]5CO)O[C@H](n5cc(C)c(N)nc5=O)[C@H]4OCCOC)O[C@H](n4cnc5c(N)ncnc54)[C@H]3OCCOC)O[C@H](n3cc(C)c(N)nc3=O)[C@H]2OCCOC)O[C@@H]1n1cc(C)c(N)nc1=O","inchiKey":"TZRFSLHOCZEXCC-HIVFKXHNSA-N","drugType":"Oligonucleotide","blackBoxWarning":true,"name":"MIPOMERSEN","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Mipomersen"],"crossReferences":{"DailyMed":["mipomersen%20sodium"],"DrugCentral":["4747"]},"childChemblIds":["CHEMBL502097"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000084674"],"count":1},"linkedDiseases":{"rows":["HP_0003124","EFO_0000319","EFO_0004911"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for cardiovascular disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2323775","canonicalSmiles":"Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1","inchiKey":"VMJFTOSOFDEKTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-8033","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8033","MK8033","Mk-8033"],"count":1,"linkedTargets":{"rows":["ENSG00000164078","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL238502","canonicalSmiles":"CCCCCCC(N)=O","inchiKey":"AEDIXYWIVPYNBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTANAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octanoylamide"],"crossReferences":{"drugbank":["DB02641"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL242469","canonicalSmiles":"C[C@@]1(C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)CC(C(F)(F)F)=NN1","inchiKey":"RYBKPGYFXRNMMU-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL242469","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13936"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243580","canonicalSmiles":"c1ccc2c(c1)[nH]c1ccccc12","inchiKey":"UJOBWOGCFQCDNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9H-Carbazole","Carbazole"],"crossReferences":{"PubChem":["144208901","144213164","17389991","26752943","47193682"],"Wikipedia":["Carbazole"],"drugbank":["DB07301"],"chEBI":["27543"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253896","canonicalSmiles":"COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1","inchiKey":"ORXQGKIUCDPEAJ-YRNVUSSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANTHOHUMOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Xanthohumol"],"crossReferences":{"Wikipedia":["Xanthohumol"],"drugbank":["DB15359"],"chEBI":["66331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL256087","canonicalSmiles":"CC1CCC(C(C)C)C(O)C1","inchiKey":"NOOLISFMXDJSKH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MENTHOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aqua-cool","Aquasoothe","Arjun","Catarrh","Dermacool","Fisherman's friend lozenges","Halls","Karvol","Lockets","Meggezones","Muirs","Therapeutic mineral ice","Tixylix decongestant inh","Vocalzone"],"synonyms":["Dl-menthol","FEMA NO. 2665","Menthol","Racementhol"],"crossReferences":{"PubChem":["144207208","144213774","26754473","29215309"],"chEBI":["25187"]},"count":14,"approvedIndications":["HP_0003326","EFO_0002506","EFO_0005856","EFO_0003843","EFO_1000941","EFO_1001434"],"linkedTargets":{"rows":["ENSG00000144481","ENSG00000104321"],"count":2},"linkedDiseases":{"rows":["HP_0012735","EFO_0005856","EFO_0003768","HP_0003394","EFO_0003843","EFO_1000941","EFO_0007214","EFO_0002496","EFO_0000537","EFO_1000783","HP_0003326","MONDO_0001056","EFO_0004517","EFO_0002506","HP_0002015","MONDO_0002258","EFO_1001434"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 6 approved and 8 investigational indications."}
{"id":"CHEMBL264669","canonicalSmiles":"c1ccc(NCc2cccnc2)cc1","inchiKey":"BJXLHKJBRORJJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL264669","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["14725365"],"drugbank":["DB06851"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273481","canonicalSmiles":"NCc1cc(O)no1","inchiKey":"ZJQHPWUVQPJPQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MUSCIMOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Muscimol","NSC-333569"],"crossReferences":{"PubChem":["11111210","11113437","90341084"],"Wikipedia":["Muscimol"],"drugbank":["DB12458"],"chEBI":["7035"]},"childChemblIds":["CHEMBL1256363"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL276864","canonicalSmiles":"NCCCc1ccccc1","inchiKey":"LYUQWQRTDLVQGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Phenyl-Propylamine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Phenyl-Propylamine","3-Phenylpropylamine"],"crossReferences":{"drugbank":["DB04410"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278462","canonicalSmiles":"CC(C)(C)CCC#C[C@@H]1C[C@H]1c1c[nH]cn1","inchiKey":"CVKJAXCQPFOAIN-VXGBXAGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPRALISANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cipralisant","GT-2331"],"crossReferences":{"Wikipedia":["Cipralisant"]},"childChemblIds":["CHEMBL2106003"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL288010","canonicalSmiles":"CC(C)CCN(C[C@@H](O)[C@@H]1Cc2ccc(cc2)OCCCC(=O)N[C@@H](C(C)C)C(=O)N1)S(=O)(=O)c1ccccc1","inchiKey":"WRUVOSYKHXGAQN-GKRYNVPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL288010","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298406","canonicalSmiles":"CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21","inchiKey":"DMJWENQHWZZWDF-PKOBYXMFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECOPIPAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ecopipam","SCH-39166"],"crossReferences":{"PubChem":["144204748","170466462"],"drugbank":["DB12273"]},"childChemblIds":["CHEMBL1535402","CHEMBL1822916"],"count":5,"linkedTargets":{"rows":["ENSG00000184845"],"count":1},"linkedDiseases":{"rows":["Orphanet_510","EFO_0004895","EFO_0004699","EFO_0004270","MONDO_0002182"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL298734","canonicalSmiles":"NC(=O)N1CCC(CC(=O)N2CCC([C@H]3c4ncc(Br)cc4CCc4cc(Cl)cc(Br)c43)CC2)CC1","inchiKey":"DHMTURDWPRKSOA-RUZDIDTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LONAFARNIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lonafarnib","SCH 66336","SCH-66336","SCH66336"],"crossReferences":{"Wikipedia":["Lonafarnib"],"drugbank":["DB06448"]},"count":18,"linkedTargets":{"rows":["ENSG00000168522","ENSG00000257365"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_1001779","EFO_0006859","MONDO_0004192","MONDO_0008170","EFO_1001465","MONDO_0007254","Orphanet_740","EFO_0007304","EFO_0003060","MONDO_0020654","MONDO_0001187","EFO_0009708","EFO_1001951","MONDO_0002691","EFO_0000339","MONDO_0020732","EFO_0000574","EFO_0002499","MONDO_0024880","EFO_1000158"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 18 investigational indications."}
{"id":"CHEMBL307500","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CC[C@H](O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"CMXKUJNZWYTFJN-XFUVECHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL307500","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01554"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3099695","canonicalSmiles":"N#Cc1ccc([C@H]2CCc3cncn32)c(F)c1","inchiKey":"USUZGMWDZDXMDG-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSILODROSTAT","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LCI-699-NX","LCI699-NX","Osilodrostat"],"crossReferences":{"DailyMed":["osilodrostat%20phosphate"],"drugbank":["DB11837"]},"childChemblIds":["CHEMBL3707393"],"count":8,"approvedIndications":["EFO_0005539"],"linkedTargets":{"rows":["ENSG00000160882"],"count":1},"linkedDiseases":{"rows":["EFO_0005539","EFO_0003086","EFO_0003099","EFO_0001421","EFO_1002032","HP_0011736","EFO_1001110","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for adrenal gland disease and has 7 investigational indications."}
{"id":"CHEMBL31088","canonicalSmiles":"CNCCc1ccc(O)c(O)c1","inchiKey":"NGKZFDYBISXGGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXIEPINEPHRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111083","124879903","26755669","90341311"],"Wikipedia":["Deoxyepinephrine"],"drugbank":["DB13917"],"chEBI":["10554"]},"childChemblIds":["CHEMBL1256484"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL311300","canonicalSmiles":"Nc1nc2c(Cc3cccnc3)c[nH]c2c(=O)[nH]1","inchiKey":"DOHVAKFYAHLCJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PELDESINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCX-34","Peldesine"],"crossReferences":{"drugbank":["DB02568"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL311932","canonicalSmiles":"COc1ccc(S(=O)(=O)N(CC(=O)NO)CC(C)C)cc1","inchiKey":"JIRXORZYIXSWOB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL311932","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08271"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137311","canonicalSmiles":"Cl.O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1","inchiKey":"ISPRRZDPZDVHLE-OZYANKIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRADANICLINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1258006","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bradanicline hydrochloride","TC-5619-023"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182733","canonicalSmiles":"CCCN[C@H]1CCc2nc(N)sc2C1.Cl.Cl.O","inchiKey":"APVQOOKHDZVJEX-QTPLPEIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMIPEXOLE DIHYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL301265","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mirapex","Mirapex Extended Release","Mirapex er","Pramipexole dihydrochloride"],"synonyms":["PNU-98528E","Pramipexole dihydrochloride","Pramipexole dihydrochloride anhydrous","Pramipexole dihydrochloride monohydrate","Pramipexole hydrochloride hydrate","SND-919CL2Y","SND919CL2Y"],"crossReferences":{"DailyMed":["pramipexole%20dihydrochloride"],"PubChem":["144212633"],"chEBI":["51147"]},"count":3,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0000289","EFO_0002508","EFO_0000253","EFO_0004270"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for parkinson's disease and has 2 investigational indications."}
{"id":"CHEMBL3183419","canonicalSmiles":"CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"GEDOQFVTNIIKNX-ONAKXNSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183419","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1229","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205033"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186515","canonicalSmiles":"CC(NN)c1ccccc1.O=S(=O)(O)O","inchiKey":"XTODHAAOYCGVIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186515","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1909283","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206836"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL323533","canonicalSmiles":"C[C@]12CC[C@H]3C(=CCc4cc(O)ccc43)[C@@H]1CCC2=O","inchiKey":"WKRLQDKEXYKHJB-HFTRVMKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EQUILIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Equilin"],"crossReferences":{"PubChem":["144212958","56422880","8139975"],"Wikipedia":["Equilin"],"drugbank":["DB02187"],"chEBI":["42309"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3235499","canonicalSmiles":"O=C(Oc1ccc([76Br])cc1)N1CCN2CCC1CC2","inchiKey":"RXLOZRCLQMJJLC-RGEMYEQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3235499","maximumClinicalTrialPhase":0,"parentId":"CHEMBL559478","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325414","canonicalSmiles":"O=C(O)CC[C@H](NC(=O)c1ccc(S(=O)(=O)N2CCC[C@@H]2C(=O)O)cc1)C(=O)O","inchiKey":"NDDOUBGQRWFVQM-QWHCGFSZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL325414","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04503"],"chEBI":["46068"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3287218","canonicalSmiles":"Cc1cc(-c2ccc3c(c2)CC[C@H]3N2CC3(CCN(C(=O)Cc4cn5cc(C)sc5n4)CC3)C2)ncn1","inchiKey":"ZIUDADZJCKGWKR-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-5190457","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-5190457","Pf-05190457","Pf-5190457"],"crossReferences":{"drugbank":["DB14870"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL329091","canonicalSmiles":"Nc1ncc2ncn(CC3(OCP(=O)(O)O)CC3)c2n1","inchiKey":"KDNSSKPZBDNJDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LB80331","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LB80331"],"crossReferences":{"drugbank":["DB15671"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3304244","canonicalSmiles":"Cc1nn(-c2ncccc2CO)cc1CN1CCC2(CC1)OCC(F)(F)c1cc(Cl)sc12","inchiKey":"NKQHBJNRBKHUQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2940094","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTRX-246040","Btrx-246040","J3.309.394B","Ly-2940094"],"childChemblIds":["CHEMBL3236487"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3309923","canonicalSmiles":"COc1cc2ncnc(Oc3cccc(N[11C](=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC.Cl","inchiKey":"XCZIYUDQUDWQHI-NCFRKMOGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3309923","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2029988","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3353410","canonicalSmiles":"C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C","inchiKey":"DUYJMQONPNNFPI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSIMERTINIB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tagrisso"],"synonyms":["AZD-9291","AZD-9291 FREE BASE","AZD9291","Azd-9291","Osimertinib"],"crossReferences":{"DailyMed":["osimertinib%20mesylate"],"drugbank":["DB09330"]},"childChemblIds":["CHEMBL3545063","CHEMBL4472934"],"count":11,"approvedIndications":["EFO_0000616","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000571","MONDO_0008903","MONDO_0021117","EFO_0005842","EFO_0000313","EFO_0000707","MONDO_0024880","EFO_0000228","EFO_0003060","EFO_0000519","EFO_0000311"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 8 investigational indications."}
{"id":"CHEMBL337577","canonicalSmiles":"N[C@@H](Cn1c2c(c(=O)[nH]c1=O)CCC2)C(=O)O","inchiKey":"VSGUEKZRMJVQOH-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL337577","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29215506"],"drugbank":["DB03240"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527358","canonicalSmiles":"CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)N[C@@H](C(N)=O)C(C)C)CO2","inchiKey":"QBDVVYNLLXGUGN-XGTBZJOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PPI-2458","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ppi-2458"],"crossReferences":{"drugbank":["DB05864"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544930","drugType":"Small molecule","blackBoxWarning":false,"name":"SC-80036","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sc-80036"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545132","drugType":"Antibody","blackBoxWarning":false,"name":"MIRVETUXIMAB SORAVTANSINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMGN-853","IMGN853","Mirvetuximab soravtansine"],"count":6,"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000110195","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000167552","ENSG00000137267","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":16},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002158","MONDO_0015686","EFO_1000238","MONDO_0008170","MONDO_0011962","EFO_1000231","MONDO_0007254","EFO_0000305"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545301","drugType":"Small molecule","blackBoxWarning":false,"name":"HMPL-523","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hmpl-523"],"count":6,"linkedTargets":{"rows":["ENSG00000165025"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000685","EFO_0007160","EFO_0000222","EFO_0005952","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545331","drugType":"Small molecule","blackBoxWarning":false,"name":"RPR749","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rpr749"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545376","canonicalSmiles":"COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1","inchiKey":"OLAHOMJCDNXHFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERDAFITINIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Balversa"],"synonyms":["Erdafitinib","JNJ-42756493","Jnj-42756493"],"crossReferences":{"DailyMed":["erdafitinib"],"drugbank":["DB12147"]},"childChemblIds":["CHEMBL3918638","CHEMBL3919709","CHEMBL3975791","CHEMBL3948043"],"count":13,"approvedIndications":["EFO_0000294","EFO_0008528"],"linkedTargets":{"rows":["ENSG00000066468","ENSG00000068078","ENSG00000077782","ENSG00000160867"],"count":4},"linkedDiseases":{"rows":["EFO_0000294","EFO_0000616","EFO_0003863","EFO_0001421","EFO_0000182","MONDO_0007254","EFO_0008528","EFO_0000196","EFO_0000673","EFO_0001378","EFO_0000574","EFO_0000708","EFO_0003060"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for bladder tumor and urothelial carcinoma and has 11 investigational indications."}
{"id":"CHEMBL3545381","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-7486","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plx-7486"],"count":1,"linkedTargets":{"rows":["ENSG00000140538","ENSG00000182578","ENSG00000148053","ENSG00000198400"],"count":4},"linkedDiseases":{"rows":["MONDO_0002171"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL359164","canonicalSmiles":"Nc1ccn([C@@H]2CO[C@H](CO)O2)c(=O)n1","inchiKey":"RXRGZNYSEHTMHC-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROXACITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-ODDC","BCH-4556","Lamivudine impurity i","Lamivudine impurity i rs","Troxacitabine"],"crossReferences":{"Wikipedia":["Troxacitabine"],"drugbank":["DB04961"]},"count":1,"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000146143","ENSG00000062822","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":11},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0000222"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3621988","canonicalSmiles":"Nc1cc(F)ccc1NC(=O)c1ccc(CNC(=O)/C=C/c2cccnc2)cc1","inchiKey":"SZMJVTADHFNAIS-BJMVGYQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUCIDINOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Epidaza in china"],"synonyms":["CS-055","CS055","Chidamide","HBI-8000","Tucidinostat"],"crossReferences":{"drugbank":["DB06334"]},"count":24,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 24 investigational indications."}
{"id":"CHEMBL367463","canonicalSmiles":"CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2","inchiKey":"TVQZAMVBTVNYLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRANOPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pranoprofen"],"crossReferences":{"PubChem":["144206154","170465811","50113024"],"Wikipedia":["Pranoprofen"],"drugbank":["DB13514"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3696475","canonicalSmiles":"Cc1c([C@@H](O)CN2CCN(C[C@H](O)c3ccc4c(c3C)COC4=O)CC2)ccc2c1COC2=O","inchiKey":"OCKGFTQIICXDQW-ZEQRLZLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-7145","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-7145"],"crossReferences":{"drugbank":["DB11968"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707284","drugType":"Small molecule","blackBoxWarning":false,"name":"FERRIC SODIUM CITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferric sodium citrate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707317","drugType":"Small molecule","blackBoxWarning":false,"name":"LOREDIPLON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gf-015535-00","Lorediplon"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707331","canonicalSmiles":"C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"FIVSJYGQAIEMOC-ZGNKEGEESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLAPITANT","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Varuby"],"synonyms":["Rolapitant"],"crossReferences":{"DailyMed":["rolapitant%20hydrochloride"],"drugbank":["DB09291"]},"childChemblIds":["CHEMBL3707330"],"count":3,"approvedIndications":["EFO_0006911","HP_0002018"],"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","EFO_0004888","EFO_0000691","HP_0002018"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for chemotherapy-induced nausea and vomiting and nausea and has 1 investigational indication."}
{"id":"CHEMBL3707371","canonicalSmiles":"CC(CN1c2ccccc2Sc2ccccc21)[N+](C)(C)CCO","inchiKey":"PDSVTRQOBUIQBQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXYETHYLPROMETHAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydroxyethylpromethazine"],"crossReferences":{"drugbank":["DB13840"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL37853","canonicalSmiles":"O=C(O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(Cl)c1","inchiKey":"VJGGHXVGBSZVMZ-QIZQQNKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPROSTENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217531"],"drugbank":["DB11507"]},"childChemblIds":["CHEMBL1520583"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379652","canonicalSmiles":"OCCCO","inchiKey":"YPFDHNVEDLHUCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,3-PROPANEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,3-Propanediol"],"crossReferences":{"PubChem":["144211067"],"Wikipedia":["1,3-Propanediol"],"drugbank":["DB02774"],"chEBI":["16109"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL383208","canonicalSmiles":"N[C@@H](CC1CCCCC1)C(=O)O","inchiKey":"ORQXBVXKBGUSBA-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL383208","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02884"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL389029","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)C[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"DBLVDAUGBTYDFR-SWMBIRFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIVIDOMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lividomycin"],"crossReferences":{"drugbank":["DB04728"],"chEBI":["71961"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3894333","canonicalSmiles":"Cc1cc(C)c(N)c(C#Cc2cccc(F)c2)n1.Cl","inchiKey":"BDXXMGYKLQZXOU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3894333","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545036","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL392158","canonicalSmiles":"C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC","inchiKey":"OABRYNHZQBZDMG-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FALLYPRIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fallypride"],"crossReferences":{"drugbank":["DB15167"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3975308","canonicalSmiles":"CC(C)(O)[C@H]1CC[C@H](Nc2ccc3ncc(-c4cccc(C(F)(F)F)c4)n3n2)CC1","inchiKey":"XRNVABDYQLHODA-JCNLHEQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TP-3654","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGI-9481","TP-3654","Tp-3654"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989521","canonicalSmiles":"CC(C)NCC(O)c1ccc(O)c(O)c1.CC(C)NCC(O)c1ccc(O)c(O)c1.O.O.O=S(=O)(O)O","inchiKey":"CUQPTVCVZLUXJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROTERENOL SULFATE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL434","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Medihaler-iso","Norisodrine"],"synonyms":["Isopropylarterenol sulfate","Isoproterenol sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL3989931","canonicalSmiles":"CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1.CS(=O)(=O)O","inchiKey":"ORZHZQZYWXEDDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ENASIDENIB MESYLATE","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989908","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Idhifa"],"synonyms":["AG-221 mesylate","CC-90007","Enasidenib mesylate"],"crossReferences":{"DailyMed":["enasidenib%20mesylate"]},"count":1,"approvedIndications":["EFO_0000222"],"linkedTargets":{"rows":["ENSG00000182054"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and is indicated for acute myeloid leukemia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989959","canonicalSmiles":"NCCONC(=O)[C@@H]1CC[C@@H]2CN1C(=O)N2OS(=O)(=O)O","inchiKey":"RSBPYSTVZQAADE-RQJHMYQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NACUBACTAM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FPI-1459","Nacubactam","RG-6080","RG6080","RO-7079901","RO7079901"],"crossReferences":{"drugbank":["DB15353"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989961","canonicalSmiles":"CCN(CC)C(=O)COC(=O)/C=C/C(=O)OC","inchiKey":"AKUGRXRLHCCENI-VOTSOKGWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPILAMIDE FUMARATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tepilamide fumarate","XP23829"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL413654","canonicalSmiles":"CSCC[C@@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](Cc1ccccc1)C(N)=O","inchiKey":"AOXOCDRNSPFDPE-UKEONUMOSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GASTRIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gastrin"],"count":1,"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL419","canonicalSmiles":"NCc1ccc(S(N)(=O)=O)cc1","inchiKey":"TYMRLRRVMHJFTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MAFENIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sulfamylon"],"synonyms":["4-homosulfanilamide","D06BA03","Mafenide","NSC-34632"],"crossReferences":{"DailyMed":["mafenide%20acetate"],"PubChem":["11112297"],"Wikipedia":["Mafenide"],"drugbank":["DB06795"],"chEBI":["6633"]},"childChemblIds":["CHEMBL1201161","CHEMBL1593568"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969 and has 1 investigational indication."}
{"id":"CHEMBL4297299","canonicalSmiles":"O=C(Cc1ccc(-c2ccc(N3CCOCC3)cc2)cn1)NCc1cccc(F)c1","inchiKey":"CMKKPJNMYLOUCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KX2-361","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KX-02","KX-2361","Kx2-361"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297358","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)CN)C(=O)N[C@H](C(=O)O)C(C)C","inchiKey":"HEEWEZGQMLZMFE-RKGINYAYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"BPC-157","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bepecin","Bpc-157","PL-10","PL-14736","PLD-116"],"crossReferences":{"drugbank":["DB11882"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297480","canonicalSmiles":"O=C(Nc1ccc(F)cc1)c1cnc(SCc2cc(OC(F)(F)F)ccc2B(O)O)nc1","inchiKey":"SDUDZBCEHIZMFZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SX-682","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SX-682","Sx-682"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297632","canonicalSmiles":"COCCOCCOCCOCCOCCOCCO[C@H]1CCC2(O)[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5","inchiKey":"RQHILGKAOIGUHU-BUCMUWKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYCODEGOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Loxicodegol","NKTR-181","Nktr-181","Oxicodegol","Oxycodegol"],"childChemblIds":["CHEMBL4298154"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297682","drugType":"Unknown","blackBoxWarning":false,"name":"ABBV-257","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abbv-257"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297695","drugType":"Unknown","blackBoxWarning":false,"name":"AQ-13","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aq-13"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297701","drugType":"Unknown","blackBoxWarning":false,"name":"BIO-11006","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIO-11006","Bio-11006"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297728","drugType":"Antibody","blackBoxWarning":false,"name":"CIRMTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cirmtuzumab","UC-961"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297836","drugType":"Unknown","blackBoxWarning":false,"name":"TAK-573","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Modakafusp alfa","TAK-573","TEV-48573","Tak-573"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297842","drugType":"Antibody","blackBoxWarning":false,"name":"TOMUZOTUXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tomuzotuximab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297922","drugType":"Unknown","blackBoxWarning":false,"name":"TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 9","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cd137","Tumor necrosis factor receptor superfamily member 9"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297927","drugType":"Unknown","blackBoxWarning":false,"name":"LUMEFANTRINE CO-ARTEMETHER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPG-56697","Coartem","Lumefantrine co-artemether"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297940","drugType":"Protein","blackBoxWarning":false,"name":"ACLERASTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aclerastide","DSC127","Dsc127","USB-001","USB-005","USB005"],"count":1,"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298172","canonicalSmiles":"O=C(c1cccnc1-c1ccncc1)N1CCC(O)(Cc2ccccc2)CC1","inchiKey":"XKUZMIUSBMCVPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOTICLESTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OV-935","OV935","Soticlestat","TAK-935"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298202","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PELACARSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AKCEA-APO(a)-LRx","ISIS 681257","ISIS-681257 FREE ACID","Ionis-apo(a)-lrx","Pelacarsen"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298212","drugType":"Antibody","blackBoxWarning":false,"name":"RAVAGALIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-323","PR-1629977","Ravagalimab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL434492","canonicalSmiles":"COCCOC[C@H](CC1(C(=O)N[C@H]2CC[C@@H](C(=O)O)CC2)CCCC1)C(=O)O","inchiKey":"ACZWIDANLCXHBM-HRCADAONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDOXATRILAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Candoxatrilat","UK-73,967","UK-73967"],"crossReferences":{"drugbank":["DB11623"],"chEBI":["3354"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45","canonicalSmiles":"COc1ccc2[nH]cc(CCNC(C)=O)c2c1","inchiKey":"DRLFMBDRBRZALE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELATONIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Circadin","General nutrit","Health aid","Heidadouppi","Icenia","Life ext","Melapure","Natrol","Nature's blend","Natures bounty","Quality health","S.gard","Travelag","Vespro","Vytalonin"],"synonyms":["BCI-049","J5.258B","Melatonin","N-(2-(5-Methoxy-1H-Indol-3-Yl)Ethyl)Acetamide","N-Acetyl-5-Methoxytryptamine","NSC-113928","NSC-56423"],"crossReferences":{"PubChem":["104171188","105815","11111468","124880734","124880739","144208725","144213243","170465589","17388930","17389536","26747238","26752764","46500483","50105414","85231137","90340716"],"Wikipedia":["Melatonin"],"drugbank":["DB01065"],"chEBI":["16796"]},"count":54,"linkedTargets":{"rows":["ENSG00000168412","ENSG00000134640"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000275","MONDO_0002009","EFO_0000555","EFO_0000756","EFO_0003768","HP_0031217","EFO_0004698","HP_0000938","HP_0100543","HP_0040187","EFO_1000824","HP_0012378","EFO_0000400","EFO_0000692","EFO_0003940","MONDO_0002635","EFO_1001904","EFO_0003888","EFO_0003756","EFO_0002687","EFO_0002508","EFO_0003821","EFO_0003758","EFO_0000701","EFO_0009516","Orphanet_2382","EFO_0001666","EFO_0000660","HP_0100806","MP_0001914","MONDO_0100096","EFO_0005800","EFO_0007282","EFO_0004723","EFO_0005687","HP_0000726","MONDO_0024290","EFO_1001905","MONDO_0007254","EFO_0009267","EFO_0008568","EFO_0000274","EFO_0000495","EFO_0009579","EFO_0003948","EFO_0000474","MONDO_0002050","EFO_0000289","MONDO_0021698","EFO_1001216","MONDO_0005299","EFO_0003917","EFO_0005230","EFO_0007462","EFO_0000616","EFO_0000280","EFO_0006859","EFO_0000545","HP_0002140","EFO_0003958","EFO_0003929","EFO_0003843","EFO_0003060","EFO_0002615","EFO_0000311","EFO_0000537","EFO_0000195","EFO_0000589","EFO_0003885","HP_0002172","EFO_1001121","EFO_0001421","EFO_0000199","EFO_0008583","MONDO_0024880","EFO_0005411","EFO_0003918"],"count":78},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 54 investigational indications."}
{"id":"CHEMBL458997","canonicalSmiles":"CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl","inchiKey":"UYJNQQDJUOUFQJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL458997","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103904601"],"drugbank":["DB07460"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594311","drugType":"Gene","blackBoxWarning":false,"name":"BETIBEGLOGENE AUTOTEMCEL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Betibeglogene autotemcel","LentiGlobin BB305"],"description":"Gene drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594421","canonicalSmiles":"[2H]C([2H])([2H])NC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F","inchiKey":"WXCXUHSOUPDCQV-HPRDVNIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HC-1119","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1082407","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HC 1119","HC-1119","Hc-1119"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL467","canonicalSmiles":"NC(=O)NO","inchiKey":"VSNHCAURESNICA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HYDROXYUREA","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Droxia","Hydrea","Hydroxyurea","Siklos"],"synonyms":["Hydroxycarbamide","Hydroxyurea","NSC-32065","SQ 1089","SQ-1089"],"crossReferences":{"DailyMed":["hydroxyurea"],"PubChem":["11111283","144210638","170465025","174007362","26747533","50106399","57260119","85231078","90341681","90752"],"Wikipedia":["Hydroxycarbamide"],"drugbank":["DB01005"],"chEBI":["44423"]},"count":32,"approvedIndications":["EFO_0000616","EFO_0000756"],"linkedTargets":{"rows":["ENSG00000171848"],"count":1},"linkedDiseases":{"rows":["EFO_0008525","MONDO_0044903","EFO_0005577","Orphanet_232","EFO_0000756","EFO_1001465","EFO_0003866","Orphanet_848","MONDO_0003212","MONDO_0020657","EFO_0003817","EFO_0000565","EFO_0002430","MONDO_0001056","EFO_0004251","EFO_0000339","EFO_1001797","HP_0001871","EFO_0000712","MONDO_0008903","Orphanet_2495","EFO_1000158","EFO_0000479","EFO_0000198","EFO_0000616","MONDO_0007608","MONDO_0005149","EFO_0006859","EFO_1000642","MONDO_0007576","EFO_0000222","EFO_0000313","EFO_0000224","EFO_0002429","EFO_0003885","EFO_0005570","Orphanet_231222","EFO_0000764","EFO_0000574","EFO_0000519"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for melanoma and neoplasm and has 30 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL476937","canonicalSmiles":"NS(=O)(=O)Oc1ccc2c(c1)S(=O)(=O)C(CC1CCCCCC1)=C2","inchiKey":"BIASYWBGUYOWJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMD-486019","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-486019"],"crossReferences":{"drugbank":["DB06954"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL490665","canonicalSmiles":"CN(C(=O)/C=C/c1ccoc1)[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl","inchiKey":"DJSFYNINGIMKAG-FQJQBBMWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALFURAFINE HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL267495","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nalfurafine hydrochloride","TRK-820"],"count":2,"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["EFO_0001421","EFO_0003884"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL490672","canonicalSmiles":"CCc1cc(CC[C@]2(C3CCCC3)CC(O)=C(Cc3nc4nc(C)cc(C)n4n3)C(=O)O2)cc(CC)n1","inchiKey":"SLVAPEZTBDBAPI-GDLZYMKVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILIBUVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Filibuvir","PF-00868554","PF-868554"],"crossReferences":{"drugbank":["DB11878"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL504535","canonicalSmiles":"CCCN1CC(c2ccc(S(C)(=O)=O)cc2)=C(c2ccc(C)cc2)C1=O","inchiKey":"AXMZZGKKZDJGAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMRECOXIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAP-909","Imrecoxib"],"crossReferences":{"drugbank":["DB12354"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL515914","canonicalSmiles":"CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O","inchiKey":"QQOBRRFOVWGIMD-OJAKKHQRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZARIBINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Vascular toxicity"],"year":1976},"tradeNames":["Triazure"],"synonyms":["Azaribine","CB 304"],"crossReferences":{"PubChem":["144204429","170466075","29215005","855722"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1976 due to Vascular toxicity."}
{"id":"CHEMBL519160","canonicalSmiles":"C/C(O)=C(\\C#N)C(=O)Nc1ccc(-c2ccccc2)cc1","inchiKey":"MUVPBAIVOHJDOC-VBKFSLOCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL519160","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07443"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL522892","canonicalSmiles":"CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1","inchiKey":"PIQCTGMSNWUMAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOVITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-258","Dovitinib","GFKI-258","NVP-TKI258","TKI-258","Tki-258"],"crossReferences":{"PubChem":["103904684","137275871","50100092"],"drugbank":["DB05928"]},"childChemblIds":["CHEMBL4297063"],"count":23,"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000068078","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721","ENSG00000122025"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002108","EFO_0000756","EFO_0000681","EFO_0000349","Orphanet_44890","MONDO_0007254","EFO_1001465","EFO_0000222","MONDO_0008315","EFO_0000231","EFO_0003060","EFO_0000311","MONDO_0001187","Orphanet_892","MONDO_0001056","EFO_0003863","EFO_1000044","EFO_0000770","EFO_0002517","MONDO_0011962","EFO_0000182","EFO_0001378","EFO_1000796","EFO_0000519"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 23 investigational indications."}
{"id":"CHEMBL53904","canonicalSmiles":"OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(Cl)cc32)CC1","inchiKey":"WFPIAZLQTJBIFN-DVZOWYKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZUCLOPENTHIXOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clopenthixol","Clopenthixol cis(z)-form","Zuclopenthixol"],"crossReferences":{"Wikipedia":["Zuclopenthixol"],"drugbank":["DB01624"],"chEBI":["51364"]},"childChemblIds":["CHEMBL2360084","CHEMBL1437855"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL539077","canonicalSmiles":"Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F","inchiKey":"PNXSHNOORJKXDW-SBSPUUFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL539077","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1422","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550755","canonicalSmiles":"Cl.O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12","inchiKey":"WEIAMZKHBCLFOG-QPAIBFMUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORODESINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL218291","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BCX-1777","Forodesine HCl","Forodesine hydrochloride"],"count":5,"linkedTargets":{"rows":["ENSG00000198805"],"count":1},"linkedDiseases":{"rows":["EFO_0000095","EFO_0004289","EFO_0000574","EFO_0000311","MONDO_0000430"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL551813","canonicalSmiles":"CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)nc(N(C)C)c1CC(=O)O","inchiKey":"XEOSTBFUCNZKGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BI-671800","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Actimis","BI 671800","Bi 671800","Bi-671800"],"crossReferences":{"PubChem":["174006824"],"drugbank":["DB12524"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL563","canonicalSmiles":"CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"SYTBZMRGLBWNTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLURBIPROFEN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ansaid","Cebutid","Flurbiprofen","Froben","Froben sr","Strefen","Transact"],"synonyms":["BTS 18,322","BTS-18322","Flubiprofen","Flurbiprofen","Ocufen","U-27,182","U-27182"],"crossReferences":{"DailyMed":["flurbiprofen","flurbiprofen%20sodium"],"PubChem":["144204098","144212670","174007327","26747178","49732000","520771","855731","860839"],"Wikipedia":["Flurbiprofen"],"drugbank":["DB00712"],"chEBI":["5130"]},"childChemblIds":["CHEMBL3989754","CHEMBL1200990"],"count":12,"approvedIndications":["HP_0002829","HP_0003326","EFO_0005752","EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","EFO_0009657","HP_0003418","EFO_0003843","EFO_0005755","EFO_0003060","Orphanet_68380","HP_0002829","HP_0003326","EFO_0000649","EFO_0000764","EFO_0004272","HP_0003419","EFO_0001360","MONDO_0002258","EFO_0005752"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and has 4 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL646","canonicalSmiles":"Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2","inchiKey":"JOFWLTCLBGQGBO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIAZOLAM","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," France"," Netherlands"," Finland"," Argentina"],"classes":["Neurotoxicity"," Psychiatric toxicity"],"year":1992},"tradeNames":["Halcion","Kention","Triazolam"],"synonyms":["N05CD05","Triazolam","Triazolam civ","U-33,030","U-33030"],"crossReferences":{"DailyMed":["triazolam"],"PubChem":["144206170","50113071"],"TG-GATEs":["120"],"Wikipedia":["Triazolam"],"drugbank":["DB00897"],"chEBI":["9674"]},"count":5,"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0003890","MONDO_0002050","HP_0000726","EFO_0005230","EFO_0000692"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 5 investigational indications. It was withdrawn in United Kingdom,  France,  Netherlands,  Finland and  Argentina initially in 1992 due to Neurotoxicity and  Psychiatric toxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL674","canonicalSmiles":"CCC(CC)O[C@@H]1C=C(C(=O)O)C[C@H](N)[C@H]1NC(C)=O","inchiKey":"NENPYTRHICXVCS-YNEHKIRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSELTAMIVIR CARBOXYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oseltamivir","Oseltamivir acid","Oseltamivir carboxylate"],"crossReferences":{"drugbank":["DB02600"],"chEBI":["73139"]},"childChemblIds":["CHEMBL2296412","CHEMBL1956715","CHEMBL252187"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL676","canonicalSmiles":"NCCC(O)(P(=O)([O-])O)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"CEYUIFJWVHOCPP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMIDRONATE DISODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL834","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aredia","Pamidronate Disodium"],"synonyms":["CGP-23339AE"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL691","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C","inchiKey":"BFPYWIDHMRZLRN-SLHNCBLASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHINYL ESTRADIOL","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Estinyl","Etinestryl","Feminone","Follicoral","Lynoral"],"synonyms":["Enovid","Enovid-E","Ethinyl Estradiol","Ethinyl estradiol","Ethinylestradiol","Ethinyloestradiol","Ethynylestradiol","Ginestrene","NSC-10973","Norinyl","Ovulen","Ovulen-21","Ovulen-28"],"crossReferences":{"DailyMed":["ethinyl%20estradiol"],"PubChem":["144204698","144208489","144210731","170464983","26753042","76025"],"TG-GATEs":["55"],"drugbank":["DB00977"],"chEBI":["4903"]},"count":29,"approvedIndications":["EFO_0000616","EFO_0003894","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["EFO_0005204","EFO_1000710","MONDO_0004169","EFO_0001065","EFO_0009006","EFO_0007453","MONDO_0007254","Orphanet_586","EFO_0003882","EFO_0002950","EFO_0005924","HP_0000938","MONDO_0002050","EFO_0003932","EFO_0003047","EFO_0004215","EFO_0000616","EFO_0000685","EFO_0000765","EFO_0000545","EFO_0003821","EFO_0008560","EFO_0009315","EFO_0003894","EFO_0000660","Orphanet_3388","EFO_0004239","EFO_0000311","MP_0001914","EFO_0004220","EFO_0010269","EFO_0000095","EFO_0000764","MONDO_0011962","HP_0100607","Orphanet_881","HP_0100608","EFO_0001360"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 26 investigational indications."}
{"id":"CHEMBL71611","canonicalSmiles":"Nc1c(F)cc(S(=O)(=O)Nc2nnc(S(N)(=O)=O)s2)cc1Cl","inchiKey":"HOLJYLOVIHBQHO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL71611","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06891"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL72388","canonicalSmiles":"Cc1cn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)nc1N","inchiKey":"NJQONZSFUKNYOY-JXOAFFINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL72388","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01995"],"chEBI":["74725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL75680","canonicalSmiles":"CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12","inchiKey":"PRIGRJPRGZCFAS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOISINE A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aloisine A"],"crossReferences":{"drugbank":["DB07364"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL81","canonicalSmiles":"O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12","inchiKey":"GZUITABIAKMVPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RALOXIFENE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Evista","J22.982B","LY-139481","Raloxifene"],"crossReferences":{"DailyMed":["raloxifene%20hydrochloride"],"PubChem":["104171230","11111733","11111734","144209801","174007256","26755239","50105675","90341181"],"Wikipedia":["Raloxifene"],"drugbank":["DB00481"],"chEBI":["8772"]},"childChemblIds":["CHEMBL1116"],"count":11,"linkedTargets":{"rows":["ENSG00000140009"],"count":1},"linkedDiseases":{"rows":["HP_0000938","MONDO_0002050","EFO_0003854","EFO_0000249","MONDO_0011962","MONDO_0007254","EFO_0000673","EFO_0003882","EFO_0000692","EFO_0005411","EFO_0003922","EFO_0000660"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 11 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL827","canonicalSmiles":"COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1","inchiKey":"DUGOZIWVEXMGBE-CHWSQXEVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DEXMETHYLPHENIDATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dexmethylphenidate","Methylphenidate d-threo-form"],"crossReferences":{"DailyMed":["dexmethylphenidate%20hydrochloride"],"Wikipedia":["Dexmethylphenidate"],"drugbank":["DB06701"],"chEBI":["51860"]},"childChemblIds":["CHEMBL904"],"count":1,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0003888"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and is indicated for attention deficit hyperactivity disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL877","canonicalSmiles":"NC[C@H]1CC[C@H](C(=O)O)CC1","inchiKey":"GYDJEQRTZSCIOI-LJGSYFOKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANEXAMIC ACID","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyklo-f heavy period relief","Cyklokapron","Exacyl","Lysteda","Menstralite","Tranexamic acid"],"synonyms":["CL 65336","CL-65336","LB-1148","LB1148","NSC-291305","RP-18429","TRANS AMCHA","TRANS-AMCHA","Tranexamic acid","Trans AMCHA"],"crossReferences":{"DailyMed":["tranexamic%20acid"],"Wikipedia":["Tranexamic_acid"],"drugbank":["DB00302"],"chEBI":["48669"]},"count":43,"approvedIndications":["MP_0001914","HP_0000132"],"linkedTargets":{"rows":["ENSG00000122194"],"count":1},"linkedDiseases":{"rows":["EFO_0007442","HP_0002105","HP_0002239","EFO_1001178","MONDO_0004567","EFO_0005669","EFO_0003964","MONDO_0001416","EFO_0003931","EFO_0002506","EFO_0004253","Orphanet_1531","EFO_0004616","Orphanet_98878","HP_0008419","Orphanet_2495","EFO_0001642","MONDO_0008170","EFO_0004286","EFO_0009516","MONDO_0044881","HP_0001873","EFO_0000546","MP_0001914","MONDO_0100096","EFO_1000391","HP_0003040","EFO_0000731","EFO_0004284","EFO_0003907","EFO_1000999","HP_0031273","EFO_0005251","EFO_1001792","EFO_0004214","MONDO_0000726","EFO_0006834","MONDO_0002129","HP_0000132","EFO_0009579","EFO_0000272","EFO_0008553","Orphanet_91378","MONDO_0001187","EFO_0005531","EFO_1001801","EFO_0000326","EFO_0004272","EFO_0007490","EFO_0003963","EFO_0001645","EFO_0004198","EFO_0000311","EFO_0000713","EFO_0010680","EFO_0007440","MONDO_0021392","Orphanet_774","EFO_0004273","MONDO_0043510","EFO_0009314","EFO_0000691","EFO_0003895","EFO_0004710"],"count":64},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for menorrhagia and hemorrhage and has 41 investigational indications."}
{"id":"CHEMBL95431","canonicalSmiles":"NC(=O)c1nnn(Cc2cc(Cl)c(C(=O)c3ccc(Cl)cc3)c(Cl)c2)c1N","inchiKey":"WNRZHQBJSXRYJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBOXYAMIDOTRIAZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carboxyamidotriazole","L 651582","NSC-609974"],"crossReferences":{"PubChem":["124753387","174006266","4254373","485747","50109733"],"drugbank":["DB11960"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
